GH1 and acromegaly: Worries that constant, non-pulsatile exposure to growth hormone would lead to downregulation or desensitization of growth hormone receptors were allayed by studies in which subjects who received continuous subcutaneous infusions of growth hormone for up to 6 months were able to maintain normal serum IGF-I levels and to avoid any signs or symptoms of acromegaly ( 10 ).